DCP
TMO icon

Distillate Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Distillate Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,486
Closed -$4.28M – 135
2021
Q2 		$4.28M Buy
8,486
+958
+13% +$452K 1.19% 17
2021
Q1 		$3.44M Buy
+7,528
New +$3.59M 1.11% 22

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Distillate Capital Partners's TMO Position: Q3 2021 in Review

Distillate Capital Partners sold out of Thermo Fisher Scientific (TMO) in Q3 2021, closing a stake of 8,486 shares — an estimated $4.28M sold.

Distillate Capital Partners first reported a position in TMO in Q1 2021 and held it in 2 quarters. The position peaked at $4.28M in Q2 2021. 2,129 funds tracked by Wall St. Rank hold TMO as of Q3 2021.

  • Distillate Capital Partners reported no remaining Thermo Fisher Scientific position as of Q3 2021 after selling out during the quarter.
  • Distillate Capital Partners sold 8,486 Thermo Fisher Scientific shares in Q3 2021, an estimated $4.28M.
  • Distillate Capital Partners first reported a position in Thermo Fisher Scientific in Q1 2021 and held it in 2 quarters.
  • Distillate Capital Partners's Thermo Fisher Scientific position peaked at $4.28M in Q2 2021.
  • 2,129 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2021.

Based on Distillate Capital Partners's 13F filing for Q3 2021, filed 5 Nov 2021.